FDA Indications for use

The LazrPulsr 4X therapy laser has been cleared by the FDA for distribution and use on humans and has been granted a 510 K #041565 on March 3rd 2005.

The indications for use under this number is stated as;

For adjunctive use in providing temporary relief of minor chronic neck and shoulder pain of musculoskeletal origin.